pulmonary%20arterial%20hypertension
PULMONARY ARTERIAL HYPERTENSION
Pulmonary arterial hypertension is a syndrome resulting from restricted flow through the pulmonary arterial circulation resulting in increased pulmonary vascular resistance and ultimately leading to right heart failure.
It is a part of the spectrum of pulmonary hypertension, which is hemodynamic and pathophysiological condition defined as an increase in mean pulmonary arterial pressure ≥25 mmHg at rest.
Typical symptoms include progressive dyspnea on exertion, palpitations, fatigue, weakness, angina, syncope and abdominal distention.

Pulmonary%20arterial%20hypertension Signs and Symptoms

Introduction

  • A syndrome resulting from restricted flow through the pulmonary arterial circulation resulting in increased pulmonary vascular resistance & remodeling, & ultimately leading to right heart failure

Definition

  • Pulmonary arterial hypertension (PAH) is part of the spectrum of pulmonary hypertension (PH), which is a hemodynamic & pathophysiological condition
    • Precapillary PH defined as an increase in mean pulmonary arterial pressure (mPAP) >20 mmHg, pulmonary arterial wedge pressure (PAWP) of ≤15 mmHg, & pulmonary vascular resistance (PVR) of ≥3 Wood Units (WU), with all measurements taken at rest
    • Isolated post-capillary PH is defined as mPAP >20 mmHg, PAWP >15 mmHg & PVR <3 WU
    • Combined pre- & post-capillary PH is defined as mPAP >20 mmHg, PAWP >15 mmHg & PVR ≥3 WU

Signs and Symptoms

Typical Symptoms

  • Progressive dyspnea on exertion, palpitations
  • Fatigue, weakness, angina, syncope, abdominal distention
  • Less commonly: Hemoptysis, Raynaud’s phenomenon

Risk Factors and Associated Conditions for Pulmonary Arterial Hypertension

Drugs & Toxins
  • Definite association: Aminorex, Fenfluramine, Dexfenfluramine, Benfluorex, methamphetamines, Dasatinib, selective serotonin reuptake inhibitors, toxic grapeseed oil
  • Possible association: Cocaine, Phenylpropanolamine, L-tryptophan, chemotherapeutic agents (Mitomycin C, Cyclophosphamide), Interferon α & β, St. John’s Wort, amphetamines, Bosutinib, direct-acting antiviral agents against hepatitis C virus infection (eg Sofosbuvir), Leflunomide & Indirubin
  • Unlikely associated with PAH: Oral contraceptives, Estrogen therapy, cigarette smoking
Demographic Factors
  • Definite association: Gender
  • Possible association: Pregnancy, systemic hypertension
  • Unlikely associated with pulmonary arterial hypertension: Obesity
Medical Conditions
  • Definite association: HIV infection, severe symptomatic mitral or aortic valve disease
  • Likely association: Portal hypertension or liver disease, collagen vascular diseases, congenital systemic-to-pulmonary cardiac shunts
  • Possible association: Thyroid disorders, hematological conditions (eg asplenia 2° to surgical splenectomy, sickle cell disease, β-thalassemia, chronic myeloproliferative disorders), rare genetic or metabolic diseases (eg Type 1a glycogen storage disease, Gaucher’s disease, hereditary hemorrhagic telangiectasia)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 28 Apr 2020

Representatives from five Asian countries shared local experiences and current protocols for pharmacotherapy in treating patients with COVID-19 at a recent Asian Young Pharmacists' Group (AYPG) webinar.

Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 22 Sep 2020

Treatment with the DPP 1* inhibitor brensocatib prolonged time to exacerbation and reduced exacerbation rates in patients with non-cystic fibrosis bronchiectasis, according to the phase II WILLOW** study presented at ERS 2020.

Pearl Toh, 2 days ago
With much remains controversial regarding the possible transmission route of SARS-CoV-2 virus, a study reveals yet another surprise worthy of caution in the hospital setting.